Skip to main content
. 2018 Jan 29;15(4):4241–4247. doi: 10.3892/ol.2018.7905

Figure 3.

Figure 3.

Kaplan-Meier analysis of RFS in HLA-A*2402 matched and unmatched stage IIIa CRC groups. RFS showed no significant difference between the HLA-A*2402 matched and unmatched stage IIIa CRC groups. RFS, relapse-free survival; HLA-A, human leukocyte antigen-A; HR, hazard ratio; CI, confidence interval; CRC, colorectal cancer.